{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:12:55Z","timestamp":1791191575471,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.vaccine.2008.03.035","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T19:26:46Z","timestamp":1207942006000},"page":"2601-2614","source":"Crossref","is-referenced-by-count":45,"title":["Canine MDCK cell lines are refractory to infection with human and mouse prions"],"prefix":"10.1016","volume":"26","author":[{"given":"Magdalini","family":"Polymenidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Trusheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Stallmach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Julius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lenz-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Aguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2008.03.035_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/315320","article-title":"The impact of influenza epidemics on hospitalizations","volume":"181","author":"Simonsen","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00253-004-1874-1","article-title":"Influenza vaccines: recent advances in production technologies","volume":"67","author":"Bardiya","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2008.03.035_bib4","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/S0264-410X(98)00464-2","article-title":"Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium","volume":"17","author":"Voeten","year":"1999","journal-title":"Vaccine"},{"issue":"44\u201346","key":"10.1016\/j.vaccine.2008.03.035_bib5","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1016\/j.vaccine.2006.05.084","article-title":"Inflexal V\u2014the influenza vaccine with the lowest ovalbumin content","volume":"24","author":"Kursteiner","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.035_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/160.2.191","article-title":"Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs","volume":"160","author":"Katz","year":"1989","journal-title":"J Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2008.03.035_bib7","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.vaccine.2005.04.039","article-title":"Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine","volume":"23","author":"Ghendon","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.035_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nbt1261","article-title":"Vaccine manufacturing: challenges and solutions","volume":"24","author":"Ulmer","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3181\/00379727-98-24111","article-title":"Established kidney cell lines of normal adult bovine and ovine origin","volume":"98","author":"Madin","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2008.03.035_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.138.3536.42","article-title":"Serial propagation of influenza B (Lee) virus in a transmissible line of canine kidney cells","volume":"138","author":"Green","year":"1962","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.035_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/AEM.16.4.588-594.1968","article-title":"Replication and plaque assay of influenza virus in an established line of canine kidney cells","volume":"16","author":"Gaush","year":"1968","journal-title":"Appl Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/381166","article-title":"Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents","volume":"189","author":"Vorberg","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3181\/00379727-122-31293","article-title":"Characterization of an established line of canine kidney cells (MDCK)","volume":"122","author":"Gaush","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.035_bib14","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1074\/jbc.272.10.6324","article-title":"Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform","volume":"272","author":"Naslavsky","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.035_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1073\/pnas.0408937102","article-title":"Prion protein NMR structures of cats, dogs, pigs, and sheep","volume":"102","author":"Lysek","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.035_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","article-title":"Coexistence of multiple PrPSc types in individuals with Creutzfeldt\u2013Jakob disease","volume":"4","author":"Polymenidou","year":"2005","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.035_bib17","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pmed.0030014","article-title":"Analysis of prion strains by PrP(Sc) profiling in sporadic Creutzfeldt\u2013Jakob disease","volume":"3","author":"Schoch","year":"2005","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.035_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0092-8674(94)90436-7","article-title":"No propagation of prions in mice devoid of PrP","volume":"77","author":"Sailer","year":"1994","journal-title":"Cell"},{"issue":"6741","key":"10.1016\/j.vaccine.2008.03.035_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/22241","article-title":"Prions prevent neuronal cell-line death","volume":"400","author":"Kuwahara","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.03.035_bib20","unstructured":"Polymenidou M, Moos, R, Aguzzi, A. unpublished."},{"issue":"16","key":"10.1016\/j.vaccine.2008.03.035_bib21","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody","volume":"98","author":"Enari","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5727","key":"10.1016\/j.vaccine.2008.03.035_bib22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","article-title":"Anchorless prion protein results in infectious amyloid disease without clinical scrapie","volume":"308","author":"Chesebro","year":"2005","journal-title":"Science"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.03.035_bib23","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1086\/344267","article-title":"Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages","volume":"186","author":"Race","year":"2002","journal-title":"J Infect Dis"},{"issue":"97 (18)","key":"10.1016\/j.vaccine.2008.03.035_bib24","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1073\/pnas.97.18.10248","article-title":"Species-barrier-independent prion replication in apparently resistant species","volume":"29","author":"Hill","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5919","key":"10.1016\/j.vaccine.2008.03.035_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/303706a0","article-title":"Evidence for host-cell selection of influenza virus antigenic variants","volume":"303","author":"Schild","year":"1983","journal-title":"Nature"},{"issue":"6651","key":"10.1016\/j.vaccine.2008.03.035_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/39218","article-title":"A pandemic warning?","volume":"389","author":"de Jong","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.035_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","article-title":"Avian influenza virus (H5N1): a threat to human health","volume":"20","author":"Peiris","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.03.035_bib28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","article-title":"Development of a mammalian cell (Vero) derived candidate influenza virus vaccine","volume":"16","author":"Kistner","year":"1998","journal-title":"Vaccine"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2008.03.035_bib29","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","article-title":"The human cell line PER. C6 provides a new manufacturing system for the production of influenza vaccines","volume":"19","author":"Pau","year":"2001","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2008.03.035_bib30","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.1128\/JVI.75.19.9517-9525.2001","article-title":"Characterization of a porcine lung epithelial cell line suitable for influenza virus studies","volume":"75","author":"Seo","year":"2001","journal-title":"J Virol"},{"issue":"6602","key":"10.1016\/j.vaccine.2008.03.035_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"issue":"6197","key":"10.1016\/j.vaccine.2008.03.035_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/336390a0","article-title":"Fibrils from brains of cows with new cattle disease contain scrapie-associated protein","volume":"336","author":"Hope","year":"1988","journal-title":"Nature"},{"issue":"6854","key":"10.1016\/j.vaccine.2008.03.035_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/35096710","article-title":"Japan's first BSE case fuels fears elsewhere","volume":"413","author":"Cyranoski","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.035_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/104063870701900202","article-title":"Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States","volume":"19","author":"Richt","year":"2007","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2008.03.035_bib35","first-page":"335","article-title":"TSE risk assessment for starting materials used during, or in the manufacture of vaccines for human use\u2014a consultant's view of the commercial approach","volume":"123","author":"Bradley","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.035_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0034-5288(18)34291-7","article-title":"Multiplication of scrapie agent in cell culture","volume":"11","author":"Clarke","year":"1970","journal-title":"Res Vet Sci"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2008.03.035_bib37","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1099\/0022-1317-68-5-1391","article-title":"Characterization of scrapie infection in mouse neuroblastoma cells","volume":"68","author":"Race","year":"1987","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.035_bib38","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/JVI.62.5.1558-1564.1988","article-title":"Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins","volume":"62","author":"Butler","year":"1988","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.03.035_bib39","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.035_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1290\/1071-2690(2000)036<0045:EOACLF>2.0.CO;2","article-title":"Establishment of astrocyte cell lines from sheep genetically susceptible to scrapie","volume":"36","author":"Vilette","year":"2000","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.035_bib41","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1128\/JVI.02628-06","article-title":"Prion infection of muscle cells in vitro","volume":"81","author":"Dlakic","year":"2007","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.035_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1034\/j.1600-0854.2002.31106.x","article-title":"PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts","volume":"3","author":"Sarnataro","year":"2002","journal-title":"Traffic"},{"issue":"6272","key":"10.1016\/j.vaccine.2008.03.035_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/345194c0","article-title":"BSE: spongiform encephalopathy found in cat","volume":"345","author":"Aldhous","year":"1990","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.vaccine.2008.03.035_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/vr.133.15.360","article-title":"Spongiform encephalopathy in a herd of greater kudu (Tragelaphus strepsiceros): epidemiological observations","volume":"133","author":"Kirkwood","year":"1993","journal-title":"Vet Rec"},{"issue":"20","key":"10.1016\/j.vaccine.2008.03.035_bib45","doi-asserted-by":"crossref","first-page":"11666","DOI":"10.1073\/pnas.1834432100","article-title":"A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions","volume":"100","author":"Klohn","year":"2003","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T04:43:12Z","timestamp":1588567392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0264410X08003113"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}